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Imaging Reactive Oxygen Species-Induced
Modifications in Living Systems
               Giuseppe Maulucci,1 Goran Bacic´ ,2 Lori Bridal,3 Harald HHW Schmidt,4
Bertrand Tavitian,5 Thomas Viel,5 Hideo Utsumi,6 A. Suha Yalc¸ın,7 and Marco De Spirito1
Abstract
Significance: Reactive Oxygen Species (ROS) may regulate signaling, ion channels, transcription factors, and
biosynthetic processes. ROS-related diseases can be due to either a shortage or an excess of ROS.Recent Advances:
Since the biological activity of ROS depends on not only concentration but also spatiotemporal distribution, real-time
imaging of ROS, possibly ‘‘in vivo,’’ has become a need for scientists, with potential for clinical translation. New
imaging techniques as well as new contrast agents in clinically established modalities were developed in the previous
decade. Critical Issues: An ideal imaging technique should determine ROS changes with high spatiotemporal
resolution, detect physiologically relevant variations in ROS concentration, and provide specificity toward different
redox couples. Furthermore, for in vivo applications, bioavailability of sensors, tissue penetration, and a high signal-
to-noise ratio are additional requirements to be satisfied.Future Directions: None of the presented techniques fulfill
all requirements for clinical translation. The obvious way forward is to incorporate anatomical and functional
imaging into a common hybrid-imaging platform. Antioxid. Redox Signal. 00, 000–000.
Introduction
Reactive oxygen species (ROS) such as superoxide,hydrogen peroxide, and peroxynitrite are highly reactive
in terms of oxidative modifications of biomacromolecules.
Exogenous ROS can be produced from pollutants, tobacco,
smoke, drugs, xenobiotics, or radiation; whereas endogenous
ROS are produced intracellularly through multiple mecha-
nisms. Depending on the cell and tissue types, the major
sources are NADPH oxidase (NOX) complexes (seven distinct
isoforms) in cell membranes, mitochondria, peroxisomes, and
endoplasmic reticulum (30). Mitochondria produce superox-
ide radical (O2
-) when oxygen is prematurely and incom-
pletely reduced. Superoxide can initiate lipid peroxidation in
its protonated form, hydroperoxyl HO2$, and can be converted
to hydrogen peroxide (H2O2). Myeloperoxidase (MPO),
which is released from cytoplasmic granules of activated
phagocytes by a degranulation process, reacts with H2O2 and
chloride ions to generate hypochlorous acid/hypochlorite
(HOCl/OCl(-)). HOCl, a strong oxidant, in turn, reacts with
proteins to form HOCl-modified proteins. Reactive nitrogen
species (RNS) are derived from nitric oxide (NO) and su-
peroxide (O2
-) via the enzymatic activity of inducible nitric
oxide synthase (NOS) and NOX, respectively. The reaction of
nitric oxide (NO) with superoxide (O2
-) leads to the for-
mation of peroxynitrite (ONOO-) (Fig. 1) (30).
These reactive species are essential regulators of several
physiological processes, ranging from intermediary metabolism
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to the inflammatory response. Their altered spatiotemporal
distribution plays a central role in the physiopathology of
disease (21).
An understanding of the complexity of ROS signaling
requires the determination of their spatiotemporal distribu-
tion with high resolution, specificity, and sensitivity. Toward
this aim, significant progress in ROS imaging at the level of
intact cells, tissues and whole organs, as well as living or-
ganisms was achieved in the previous decade. Among these
advancements, an important role was played by the devel-
opment of novel synthetic or genetically encoded fluorescent
ROS indicators and in vivo imaging technologies (17, 91, 96,
123, 127, 145).
In particular, the possibility of detecting ROS dynamics
in vivo has stimulated research in medical imaging with the
aim of providing new information that will be beneficial for
disease management. This area of medical imaging research
covers a wide domain of different imaging modalities, each
with its own sensitivity and resolution. Modalities include
Magnetic Resonance Imaging (MRI), Ultrasound (US), Po-
sitron Emission Tomography (PET), Single-Photon Emission
Computed Tomography (SPECT), and other optical imaging
methods (2, 51, 103, 108, 109, 138) (Fig. 1). In this context,
improvements in detection efficiency as well as new contrast
agents for these well-established modalities were developed
in the previous decade. However, low levels of intracellular
ROS require new and more sensitive methods. Here, we will
review the methods emerging to image the complexity of the
ROS dynamics in vivo with a focus on those that have po-
tential for clinical application.
Redox-Sensitive Two-Photon Microscopy
Two-photon microscopy (TPM) is a well-established sub-
micron resolution imaging technique that is characterized by
low phototoxicity and deep tissue penetration. In the two-
photon process, the probe absorbs two photons whose indi-
vidual energy is only half of the energy needed to excite that
molecule (109). TPM excitation via near infrared (NIR) laser
light reduces tissue and water absorption. Penetration depths
can reach 1 mm into biological tissues, and the reduction of
photo-bleaching, photo-damage, and phototoxicity is
achieved by the spatial confinement of excitation (109). With
these advantages, TPM has yielded novel and unique struc-
tural and functional information on cells and tissues.
In this context, determination of the spatial distribution of
redox-active compounds and their time evolution is an im-
portant issue to be addressed, since redox homeostasis,
playing a crucial role in many pathologies, can be a decisive
target for pharmaceutical intervention (30).
Several fluorescence approaches to image ROS and redox
potentials with high resolution have been attempted to ad-
dress this task. Two of them are the most promising: Two-
photon Fluorescence Ratio Imaging Microscopy (TP-FRIM)
and Two Photon Fluorescence Lifetime Imaging Microscopy
(TP-FLIM) (94, 137, 143). These techniques have allowed a
quantification of specific concentrations of intracellular re-
dox species by canceling out the possible perturbations due to
instrument efficiency and dye concentration.
In TP-FRIM, the absorption or emission spectrum is dif-
ferently sensitive to the redox state of the compound. One
wavelength range of the emission or excitation spectrum may
be less sensitive, or sensitive in the opposite direction with
respect to another selected range. Because absorption or
emission originates from the same volume, the ratio of fluo-
rescence measured in the two ranges is independent of optical
path length, probe concentration, and excitation intensity.
TP-FLIM allows for the detection of the redox state of
compounds by measuring differences in the exponential decay
rate of the fluorescence (lifetime) of the probe by single-
wavelength excitation. A quantitative determination of the re-
dox state independent of probe concentration could be obtained.
Two-photon redox-sensitive probes
Determination of the spatial distribution of different redox-
active compounds (GSH, NAD(P)H, H2O2, NO etc.) is an
important aim for diagnosis and treatment. Although a number
of probes that are able to detect fluorescence in cultured cells
are available, recent efforts have aimed at developing specific
and highly sensitive TP-FRIM and TP-FLIM-based probes to
1. Spectrum of different ROS imaging techniques. In
the upper part, different sources of ROS are shown: My-
tochondria (mito), lipid peroxides (LPO), Monoamine oxidase
(MAO), Nicotinamide adenine dinucleotide phosphate oxidase
(NOX4 and NOX 1/2/5), xanthine oxidase (XO), and Nitric
Oxide Synthases (NOS and e-NOS). These result in different
types of ROS [including Superoxide Radical (O2
-:), Hydrogen
peroxide (H2O2), Hypoclorous Acid (HOCl), Peroxynitrite
radical (ONOO-:), nitric oxide(NO)] and ROS-induced modi-
fications of GSH, NADPH, proteins, or glucose uptake, which,
in turn, are detected by different imaging technologies (for ab-
breviations and details, see text). ROS, reactive oxygen species.
To see this illustration in color, the reader is referred to the web
version of this article at www.liebertpub.com/ars
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improve a quantitative analysis of ROS in deep tissue and for
intra-vital microscopy (17, 19, 27, 79, 126, 145).
Two-photon sensitive probes for assessment
of glutathione redox state
The redox state of the reduced and oxidized glutathione
couple (GSH:GSSG), the most abundant redox couple in a cell,
is an informative readout of the cellular redox environment
(30). Glutathione-specific, redox-sensitive variants of the
Yellow Fluorescent Protein (rxYFP) and the Green Fluor-
escent Protein (roGFP1 and roGFP2) allowed FRIM real-time
monitoring in the intracellular GSH:GSSG redox ratio (92–94,
123). The specificity of these probes for glutathione was en-
hanced by linking them to human glutaredoxin 1 (Grx1) (12).
To extend in vivo use of these probes, Wolf et al. (145) gen-
erated transgenic mice expressing roGFP in several tissues to
ratiometrically monitor oxidative stress in skin epidermal
keratinocytes. However, visible excitation and emission light
do not permit a deeper penetration in tissues. As a result,
measurement of the cellular glutathione redox potential (EG)
is affected by non-negligible systematic errors (95). Further-
more, these redox probes, when linked to enzymatically active
redox proteins (i.e., Grx1), may alter cellular redox homeo-
stasis. Guzman and coworkers reported measurements of mi-
tochondrial oxidative stress on dopaminergic neurons in
transgenic mice expressing mito-roGFP, an roGFP that se-
lectively tags targeted to mitochondria, with TPM (42).
However, the suitability of this probe for potential TP-FRIM
application has yet to be tested. To overcome these issues,
several GSH-sensitive, TP-excitable, nonencoded chemose-
lective probes were engineered for in vivo applications (79).
However, even in these cases, TP-FRIM/TP-FLIM potentials
have yet to be characterized. Besides all these profuse efforts,
further improvements in the development of glutathione-
specific redox probes are still needed.
Two-photon NADPH redox state sensitive probes
The intracellular metabolic substrates NADH and NADPH
(NAD(P)H) have been used as intrinsically fluorescent probes
for metabolic states, cancer detection, and tissue oxygen sup-
ply, allowing label-free in vivo imaging of tissues (17, 97, 124,
125, 130). NAD(P)/NAD(P)H auto-fluorescence can, there-
fore, be detected and related to other different physical quan-
tities to gain further details on insight into the processes
regulating redox homeostasis. For example, the mechanism by
which noise-induced ROS mediates an impairment in acoustic
recovery capacity was elucidated by relating intracellular
distribution of NAD(P)H in a noise-stressed mammalian co-
chlea to the generation of lipid peroxides and to the spatial
organization of lipids inside membranes. This allowed a dis-
closure of the mechanism of noise-induced ROS production
and impairment in the acoustic recovery capacity (Fig. 2) (97). 
Skala et al. (127) combined cellular redox ratio, NAD(P)H and
FAD lifetime, and subcellular morphology to quantitatively
detect NAD(P)H. With this approach, metabolic and structural
modifications at the earliest stages of cancer development have
FIG. 2. Acoustic trauma induces NAD(P)H oxidation, lipid peroxidation, and loss of membrane fluidity. NAD(P)H
can be excited by a one-photon process: For example, it can absorb one photon at 375 nm, and emit one photon at 430 nm. In
the two-photon process, NAD(P)H absorbs two photons of 750 nm whose individual energy is about one half of the energy
needed to excite that molecule. NAD(P)H does not emit fluorescence in its oxidized state. (A) Representative fluorescence
NAD(P)H images at different time points (n = 5 animals per time point) after the trauma. (B) 4-HNE assays at different
times after acoustic trauma. (C) Fluidity maps at different times after acoustic trauma. (D) Reduced NAD(P)H percentages
at different times after the trauma. From the figure, the topologically differentiated NAD(P)H oxidation is also evident on
the outer, middle, and inner rows of OHCs. (E) 4-HNE concentrations at different times after acoustic trauma. (F) GP
values of hair bundle region (maximum of the GP profiles) at different times after the trauma. Adapted from Maulucci et al.
(96). Reprinted with permission of ELSEVIER. NADPH, nicotinamide adenine dinucleotide phosphate. To see this illus-
               tration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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been identified in several epithelial tissues in vivo. Moreover,
cell Phasor, a label-free, fit-free, and sensitive innovative
method that allows classification of metabolic states of cells
during differentiation, has been developed from TP-FLIM data
(129). Zhuo et al. (17) used two-photon autofluorescence and
second harmonic generation (SHG) microscopy to monitor
cancer progression and to classify normal and dysplastic human
colonic tissues. Overall, these findings demonstrate that auto-
fluorescence can provide structural and functional information
for the diagnosis and therapy of pathologic epithelial tissues.
Two-photon H2O2-sensitive probes
Hydrogen peroxide plays a key role as a cellular second
messenger in a variety of signal transduction processes (30).
Genetically encoded fluorescent proteins HyPer, HyPer-3,
and roGFP2-Orp1 enabled transient live-cell imaging and
allowed high-resolution H2O2 imaging with high specificity
(41). However, these probes are applicable only to single-
photon FRIM or FLIM and have limited application in vivo,
since they may alter redox homeostasis and are genetically
encoded. Several TP probes have been generated to monitor
the production of intracellular H2O2 (41), but their potential
TP-FRIM applications have yet to be tested. For the TP-
FRIM imaging approach, a promising probe is Peroxy
Naphthalene 1 (PN1). This probe can be excited at 750 nm,
and it has high photostability and negligible toxicity. It also
allows the determination of H2O2 distribution in live cells and
tissue by TPM (19).
Two-photon NO-sensitive probes
Many of the NO-sensitive probes are not reversible sen-
sors, as they form covalent bonds with NO. Genetically
encoded FRET-based proteins allow high-resolution NO
imaging in cell-based experiments (122). However, in vivo
applications of these probes are very limited. For NO de-
tection in an in vivo context, a TPM probe (QNO) with high
selectivity, low cytotoxicity, pH insensitivity, and long-
wavelength emission has been designed (27). QNO is com-
posed of a quinoline derivative as the fluorophore and an
o-phenylenediamine moiety as the receptor for NO, linked
with glycinamide. The probe responded to NO over a linear
range from 0.4 to 3.4 lM with a detection limit of 0.084 lM.
QNO detects NO in living cells and tissues at a depth of
180 lm. However, TP-FRIM/FLIM properties are still not
tested and further improvements in the development of NO-
specific redox probes are needed.
Chemiluminescent Imaging of ROS In Vivo
NIR fluorescence and chemiluminescence
Over the previous decade, substantial progress has been
made in the noninvasive real-time assessment of reactive
oxygen and nitrogen species in biological systems. Bioima-
ging methods based on fluorescence and reaction-based ap-
proaches have received most attention, due to their ease of
use, sensitivity, and selectivity to different reactive species,
including reactive oxygen, nitrogen, and sulfur species. A key
interest in this rapidly growing field has been the development
of chemoselective probes, that is, probes that are diagnostic
for a single reactive species. A great number of different re-
action schemes have been exploited toward achieving this
goal [reviewed in Chan et al. (16)], as summarized in Table 1. 
Moreover, the reaction-based monitoring of selective species
can be combined with targeting of the probe to specific cel-
lular organelles, as exemplified by the boronate MitoPY1 for
the imaging of mitochondrial H2O2 (24).
Although fluorophores have been used widely for cellular
imaging of reactive species, they have a number of limita-
tions that restricts their successful application to tissues and
animals. For the latter, fluorophores with absorption and
emission maxima in the near-infrared region (650–900 nm)
are required to maximize tissue penetration and, at the same
time, to minimize interference from auto-fluorescence and
hemoglobin absorption. Nagano and co-workers recently
synthesized the near-infrared fluorescent probe FOSCY-1 to
monitor reactive species in a mouse model of peritonitis
(105). As this probe reacts with several biologically relevant
reactive species, it provides general information about the
presence of oxidative events rather than about the partici-
pation of specific reactive species in vivo. In a further de-
velopment, the same group designed and synthesized novel
far-red to near-infrared probes based on Si-rhodamine to
selectively and noninvasively monitor HOCl in real time in
mice suffering from peritonitis (70). Judged by the advances
over the previous decade, it can be reasonably expected that
the development of additional reactive species-specific and
-nonspecific far-red to near-infrared fluorescent probes will
progress rapidly.
Reaction-based methods to detect reactive species are also
applicable to in vivo imaging modalities other than fluores-
cence. Chemiluminescence, for example, was used to moni-
tor oxidative events in vivo. Perhaps the most commonly used
probe is L-012, an analog of luminol (5-amino-2,3-dihydro-1,
4-phthalazinedione) that produces much stronger signals than
Table 1.
Reactive species Subclassification Structure Biological Half-life(s) Reference
Hydrogen peroxide ROS H2O2 10
-5 (38)
Hydroxyl radical ROS HO 10-9 (20, 38)
Hypochlorous acid ROS HOCl ? ?
Nitric oxide RNS NO 10-3O1 (63, 106, 112, 158)
Peroxyl radical, including
alkylperoxyl and hydroperoxyl
radicals (wherein R =H)
ROS ROO 10-1O1 (20)
Peroxynitrite anion RNS ONOO- 0-2O1 (6, 106)
Superoxide anion ROS O2- 0-6 (38, 62)
ROS, reactive oxygen species.
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luminol, lucigenin, or MCLA (59). L-012 has been used
successfully to noninvasively image different inflammatory
processes in mice [26–28]. The probe reacts with several
highly reactive species rather than being specific, for exam-
ple, for O2
-, even though L-012-derived luminescence was
abolished in mice lacking phagocyte NOX activity (66).
Although much emphasis is placed on chemoselective
bioimaging, reactive species in biological systems likely
exist as mixtures of rapidly interconverting species. As a
result, the biological relevance of a single imaged species is
difficult to assess, even if its presence correlates with the
biological process studied, as exemplified earlier with L-012
in NOX2-deficient mice (66). In this context, nonspecific
probes that react with several different reactive species can
have the advantage of probably giving more general infor-
mation on a biological process (e.g., inflammation) than do
selective probes. Indeed, when combined with LC/MS/MS-
based analytical analysis of the nonreacted probe as well as
its different types of reaction products, nonselective probes
may be seen as multi-purpose probes that provide quantita-
tive information about different reactive species, as exem-
plified recently with hydroethidine (88).
Chemiluminescent nanoparticles and ROS imaging
Nanoparticles (NPs) are particles with at least one di-
mension less than 100 nm. They have different shapes,
unique physicochemical properties, and a high surface-area-
to-volume ratio. NPs have several advantages over small-
molecule probes used in cellular sensing and imaging (142).
First, NPs have stronger luminescent emission due to the
large number of molecular probes that can be loaded into
each particle. Additionally, their high surface-area-to-
volume ratio provides a higher probability for analyte de-
tection. The NPs may also protect the sensory contents from
external interference, such as undesirable enzymatic reac-
tions and nonspecific uptake by proteins. Moreover, it is also
possible to target NPs to cells and subcellular compartments
by conjugating appropriate ligand moieties onto their surface,
which will allow for enhanced targeting to cells and subcel-
lular compartments. Encapsulation and conjugation of dif-
ferent molecules, such as luminescent probes, proteins, or
DNA, provides infinite possibilities in NP design for specific
functions. In view of all of the earlier mentioned properties,
NPs are becoming widely used tools in the field of sensing
and imaging (Fig. 3) (115, 119).
Recent advances in developing various luminescence
probes have enabled monitoring of ROS in both cells and
animals. NP-based luminescent ROS sensors and their ap-
plications are summarized in Table 1. Lee et al. (77) devel-
oped peroxalate-based NPs formulated from peroxalate
esters and fluorescent dyes to image H2O2 in vivo with high
specificity and sensitivity. Peroxalate NPs are capable of
imaging H2O2 in the peritoneal cavity of mice during a
lipopolysaccharide-induced inflammatory response. The
same group has improved the method by reducing the size of
the NPs and modifying their content to detect H2O2 at
physiological concentrations (22, 78). Luminescent NPs have
also been exploited for in vivo targeting and imaging of tumor
tissues. In a recent study, chemiluminescent NPs were suc-
cessfully developed to image H2O2 as a tumor signal mole-
cule (18). Such probes improve the stability of peroxalates in
aqueous systems and are sensitive to low, physiologically
relevant concentrations of H2O2 within the physiological
range. This way of monitoring H2O2 should be helpful for a
clinical diagnosis of other ROS-related diseases.
Ultrasound in ROS Imaging
Ultrasonic imaging has been applied in many studies to
detect changes in functional blood flow and atherosclerotic
plaque associated with oxidative stress (84). Although radical
oxidants cannot currently be directly detected in a clinical
setting with ultrasound, a variety of original methods are
being developed to enable such detection. Proposed ap-
proaches vary widely, but all rely on the central principle
behind clinical contrast ultrasonography—the high sensitiv-
ity of ultrasound to echoes from gas bodies.
Contrast-enhanced ultrasound detects strong acoustic
echoes when the ultrasonic pulse encounters micrometric
gas-bubble contrast agents. A very specific acoustic signa-
ture can be obtained from microbubbles when they are
acoustically driven at levels resulting in a nonlinear re-
sponse during the compression and expansion phases of the
microbubble. Several, very different solutions for detection
of radical oxidants have been proposed based on the
 FIG. 3. Examples of NPs adapted for ROS sensing (A) Polymer-based NPs embedded with ROS sensing and reference 
                              fluorescent dyes; (B) Chemiluminescent NPs; (C) Metallic NP fluorescence quenching on oxidation of functionalized      
ROS-sensitive molecules (blue). Adapted from Uusitalo and Hempel (142). Reprinted with permission of MDPI. NP, nano- 
 particles. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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ultrasonic detection of microbubbles that are targeted to
specific ligands, which are generated by chemical reactions
or produced by micromotors.
Feasibility to detect inhibition of NOX in advanced ath-
erosclerosis has been shown in mice using targeted contrast
microbubbles bearing ligands for endothelial cell adhesion
molecules that are involved in monocyte recruitment (84).
Lipid-shelled decafluorobutane microbubbles were targeted
to P-selectin or VCAM-1 and detected with a clinical ultra-
sound system (7 MHz), 8 min after injection at regions of
atherosclerotic plaque in the aortic arch of mice. Inhibition of
NOX was associated with decreased targeted detection of P-
selectin and VCAM-1. This targeted ligand approach is the
basis for a large amount of research in ultrasonic molecular
imaging, but it remains to be a relatively indirect approach to
assess oxidative stress. A more direct, bio-sensing ultrasound
contrast agent for ROS detection has been proposed based on
chemical reactions that generate gas-forming molecules in
the presence of radical oxidants (108). In the presence of
radical oxidants, allylhydrazine oxidizes into 2-propenyl-
diazene that spontaneously undergoes a retro-ene reaction to
generate gas-forming nitrogen and propene molecules. Al-
lylhydrazine encapsulated in phospholipid liposomes (APLs)
were produced (60 to 110 nm in diameter) and injected in-
travenously in mice. Images of the liver obtained 10 min after
APL injection with a 14 MHz Siemens Acuson Sequoia 512
clinical ultrasound system were shown to present 40% higher
video intensity in mice with inflammation as compared with
mice without inflammation. APLs were specific to the hy-
droxyl radical, and it was further demonstrated that ultrasonic
detection of APLs is sensitive to radical oxidant concentrations
as low as 10lM. Even more recently, micromotor converters
(MMCs) have been designed to produce microbubbles when
H2O2 is present (104). Tubular MMCs with a platinum-coated
inner surface were constructed to break down H2O2 as fuel
while expelling an oxygen-microbubble trail. When injected in
an in vivo model for abscess in rats, contrast-specific imaging
revealed increased image brightness.
PET/SPECT In Vivo Imaging of Oxidative
Stress Using Radiotracers
The nuclear medicine imaging techniques PET and
SPECT are based on noninvasive detection of the distribution
of radioactively labeled molecules (radiotracers), and they
combine an exquisite sensitivity (down to the femtomolar
range) with a relatively low spatial resolution (one to a few
millimeters). After it has been injected intravenously, the
radiotracer circulates in body fluids, interacts with molecules
such as membrane receptors, transporters, enzymes, struc-
tural proteins, etc., and/or is transformed by local tissue
conditions, for example, blood flow, pH, redox potential, etc.
Over time, the distribution of the radiotracer is modified
according to the molecular composition of different parts of
the body, creating the contrast in PET and SPECT images.
With an ideal, that is, diffusible/high-affinity/low non-
specificity radiotracer, the laws of molecular interactions that
govern reversible binding or irreversible trapping apply and
allow derivation of truly quantitative information from the
images, such as the concentration of a target protein or the
activity of a target enzyme. Unfortunately, any PET or
SPECT radiotracer that binds directly to ROS species has not
been described so far. However, radiotracers that can image
events correlating more or less with oxidative stress are
available, that is, in increasing relevance order: (i) glucose
consumption, (ii) cellular retention depending on the cyto-
plasmic redox potential, and (iii) radiotracers targeting ROS
scavengers and the mitochondrial complex I-IV.
Imaging glucose consumption as a surrogate
of oxidative stress
The radiotracer that is most widely in use is [18F]Fluor-
odeoxyglucose (FDG), a glucose analog transported into the
cells principally by GLUT-1 and GLUT-3. FDG is trapped in
the cell cytoplasm after its phosphorylation by hexokinase to
FDG-6-phosphate. The rate of radioactivity accumulation
reflects local glucose consumption, and PET imaging with
FDG is used universally for imaging glucose-avid tissues
such as the brain or tumors. Jung et al. reported an indirect
link between FDG uptake and ROS concentrations in cancer
cell lines and tumor-bearing mice (61). They observed a
parallel reduction of 30–50% of FDG uptake and ROS con-
centration after administration of resveratrol at doses of 50–
150 lM in vitro and 100 mg kg-1 in vivo. The ROS scavenger
N-acetylcysteine had the same effect, whereas ROS inducers
had an opposite effect (20–40% increase) on FDG uptake
in vitro. Resveratrol treatment decreased the expression of
the membrane glucose transporter GLUT-1.
The report by Jung et al. suggesting a relationship between
FDG uptake and oxidative stress remains to be confirmed by
other studies. In fact, a number of separate studies tend to
indicate that increased oxidative stress is associated with
glucose hypometabolism in neurodegenerative disorders,
(99). Thus, it is likely that FDG uptake and ROS production
are indirectly linked to other co-occurring factors. Further
studies are necessary to determine whether the possibility to
image changes in ROS production using PET imaging is
relevant to specific diseases and/or to particular pharmaco-
logical challenges.
Radiotracers with redox potential-dependent
cellular retention
Popular SPECT radiotracers for imaging tissue perfusion,
such as [99mTc]-HMPAO, [99mTc]-HL-91, and [99mTc]-MIBI,
are redox couples that, depending on the redox potential of the
medium, can switch from a reduced, lipophilic, membrane-
permeable form to an oxidized, hydrophilic, nonmembrane-
permeable form. These radiotracers have high octanol-water
coefficients and cross cell membranes freely in a few seconds.
Once in the intracellular space, they are oxidized in the cytosol
by glutathione or reduced proteins and the radioactive signal
builds up through trapping of the membrane-impermeable
oxidized form, leading to radioactivity concentrations that are
proportional to perfusion in the normally perfused brain or
myocardium for [99mTc]-HMPAO and [99mTc]-MIBI, re-
spectively [43–44]. Conversely, defects in tissue perfusion
after stroke or myocardial ischemia appear as a negative
contrast on scintigraphic or SPECT images. Interestingly, the
trapping of these radiotracers is also impaired after oxidative
stress, suggesting that [99mTc]-HMPAO and [99mTc]-MIBI
can negatively image changes in the cellular redox state, al-
though it is not clear whether the cause is a drop in glutathione
concentration or a modification of the redox status (101).
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Sasaki et al. examined the redox potential in the brains of
young and old male DBF1 mice using [
99mTc]-HMPAO, glu-
cose transport, and metabolism using [1-14C]2-deoxy-D-
glucose (2-DG), and mitochondrial electron transport function
using [15O]O2 (121). They found a decrease of [
99mTc]-
HMPAO brain uptake at 24 and 30 months of age, a late
decrease of [15O]O2 uptake at 30 months, and a trend toward
increased 2-DG uptake with aging. Blankenberg and col-
leagues (13) used [99mTc]-HMPAO to evaluate the efficacy of
a novel redox-modulating agent in patients with rare and fatal
mitochondrial brain diseases, including Leigh syndrome,
polymerase c deficiency, MELAS, Friedreich ataxia, Kearns–
Sayre syndrome, Pearson syndrome, and mtDNA depletion
syndrome. Although no control group could be included for
obvious ethical reasons and the number of patients was limited,
they observed a significant correlation between clinical im-
provement after treatment and reduced 99mTc-HMPAO brain
uptake, suggesting that [99mTc]-HMPAO may be a useful
marker of redox state in brain regions under conditions of
chronic oxidative stress.
Radiotracers with hypoxia-dependent cellular retention
Radiotracer imaging of hypoxia is based on the principle of
free diffusion according to plasma flow followed by specific
trapping of the radiotracer in hypoxic tissues. Several ra-
diotracers are based on nitroimidazole derivatives such as the
fluorine-18-labeled fluoromisonidazole ([18F]FMISO). Once
inside the cell, the nitro group of [18F]FMISO is reduced to a
nitro radical anion that is immediately reoxidized by oxygen
in normoxic conditions. Conversely, under low oxygen
pressure, [18F]FMISO is not re-oxidized but undergoes fur-
ther reduction by electron transfer, leading to reactive species
that form adducts with proteins and nucleic acids. Since ra-
dioactivity is trapped in hypoxic conditions, [18F]FMISO
administration produces positive images of tissue hypoxia,
that is, the lower the oxygen pressure, the higher the radio-
activity concentration. However, the relationship between
uptake and hypoxia is not straightforward in all tissues be-
cause of the complex metabolism of [18F]FMISO and be-
cause of its slow clearance from normoxic tissue (102),
whereas 18F has a half-life of less than 2 h. In attempts to
obtain more suitable radiotracers, other nitroimidazole de-
rivatives such as [18F]-, [124I]-, and [123I]-azomycin deriva-
tives (IAZA, IAZGP, FAZA, respectively) (103) have been
developed for PET and SPECT imaging, as well as non
nitroimidazole compounds, including [62Cu]- and [64Cu]-
PTSM, [99mTc]-ATSM, [99mTc]-HL-91, etc, have been de-
veloped. (5). Several of these compounds are commercially
available and are in clinical use for the staging of tumors
according to their hypoxic status and/or to assess radiother-
apy- or chemotherapy-induced hypoxia. Consensus on the
utilization of hypoxia tracers and on the correlation between
their capacity to image hypoxia and ROS production remains
to be defined.
Radiotracers targeting ROS scavengers
or mitochondrial complex I-IV
An ‘‘old’’ radiotracer that recently regained interest is [99m
Tc]-DTPA–glutathione ([99m Tc]-GSH), a labeled derivative
of the intracellular tripeptide glutathione that is present in all
tissues where its physiological function is to neutralize ROS
(31). The transporter of GSH is overexpressed in cancer cells,
leading to higher concentrations of GSH in tumors, in par-
ticular during multidrug and radiation resistance and in met-
astatic cancers. It was recently reported that the uptake of [99m
Tc]-GSH is high in CT-26 colon cancer xenografted in mice
with tumor-to-muscle ratios reaching 4.3 at 4 h, compared
with 2.0 in inflammatory tissue with lower ROS levels (67).
There have been continuous efforts by Japanese groups to
develop radiotracers directly targeting the mitochondrial
complex I-IV (MC I-IV) of the respiratory electron transport
chain. Sasaki et al. have reported the labeling of [11C]ide-
benone, a coenzyme Q (CoQ)-related compound, and com-
pared its biodistribution with that of [11C]CoQ0 (120).
Although [11C]CoQ0 was better retained in cerebral tissue
than [11C]idebenone, its clearance from the blood circulation
was too slow for in vivo imaging of the brain given the half-
life of carbon-11 (20.4 min). The authors concluded that
further modifications of the isoprenoid side chain in
[11C]CoQ would be necessary to obtain more suitable ra-
diopharmaceuticals. Recently, Tsukada et al. developed
fluorine-18 derivatives of BMS-747158–01, an inhibitor of
the PSST subunit of MC I, among which [18F]F-BCPP-EF
showed interesting pharmacokinetics in rats and monkeys,
with rapid uptake into the brain and heart followed by gradual
elimination (138). Specificity of the uptake was demonstrated
using predosing with rotenone as a specific MC-I inhibitor.
[18F]F-BCPP-EF was used to image the extent of neuronal
damage in a rat model of brain ischemia, and the age-
associated neuronal impairment of MC I activity in the brain
of living monkeys (Fig. 4).
Magnetic Resonance Modalities
Basic principles and technical considerations
Electron paramagnetic resonance, EPR (or equivalently,
electron spin resonance) is a spectroscopic technique that can
directly detect paramagnetic species (species having an
electronic spin due to the unpaired electron). However, there
is very little to be observed by EPR in biological systems
apart from some stable carbon-centered radicals, melanin, or
transition metals. ROS such as superoxide or the hydroxyl
radical are much too short lived to be detected by conven-
tional EPR. Therefore, EPR detection of ROS can be ac-
complished by techniques that are not always direct. The
scheme in Figure 5 explains the basic principles and strate-
gies in ROS imaging. Injection of an EPR-visible nitroxide
allows its detection in various organs in vivo. Endogenous
ROS react with nitroxide, reducing it to an EPR-silent hy-
droxylamine and thus diminishing the EPR signal. The rate of
reduction is the measure of the redox status of the tissue. But
one has to be careful when interpreting such data, since the
signal decay rate depends on several kinetic factors such as
the distribution of the spin probe from the blood to the tissue
and vice versa, urinary excretion through kidneys, and fecal
excretion through liver and bile. Nevertheless, EPR moni-
toring of the decay rate of the injected nitroxide is the most
efficient way to assess the redox metabolism in vivo, since
one can use various nitroxides to unravel different processes.
The alternative to this approach is to use acyl-protected hy-
droxylamine, which, introduced in the tissue, can be easily
deprotected inside cells by intracellular esterases and then
converted to the EPR-visible species by ROS-induced
ROS IMAGING 7
ARS-2015-6415-ver9-Maulucci_1P.3d 05/26/16 5:11pm Page 7
oxidation [58]. An entirely different approach to ROS im-
aging is EPR spin trapping, which is the ‘‘true’’ ROS imag-
ing. The method relies on introducing a compound that will
trap short-lived radicals and convert them into more stable
paramagnetic compounds (Fig. 5).
Unfortunately, trapped radicals usually have rather com-
plex EPR spectra that are not suitable for imaging. However,
since multiple EPR lines do not affect overall paramagnetic
properties of the compound, MRI has been successfully used
in immuno-spin trapping (136).
Most of the basic principles of in vivo EPRI/EPRS were
established in the 1980s (4, 7, 9, 26, 29, 60, 100, 111, 133).
Much of this work has been stimulated by the discovery that
nitroxides can report on the redox metabolism in cells and
tissues and that the rate of reduction is highly dependent on the
concentration of oxygen [see e.g., (131)]. Since then, several
research groups have been developing specific spin probes with
an adequate in vivo lifetime and other desirable properties, as
well as instruments that are suitable for in vivoEPR. A standard
commercial EPR spectrometer operating at 9.5 GHz (X-band)
FIG. 4. Typical MR and PET images of 18F-BCPP-EF in (A) normal young, (B) rotenone-treated young, and (C) normal
old monkeys (Macaca mulatta). After infusion of vehicle (A, C) or rotenone at 0.1 mg/kg/h (B) for 1 h, PET scans were
acquired for 91 min after 18F$BCPP-EF injection with sequential arterial blood sampling. The binding of 18F-BCPP-BF to
MC-l was calculated using Logan graphical analysis with rnetabolite-corrected plasma input. Adapted from Tsukada et al.
(139). Reprinted with permission of Springer. MRI, magnetic resonance imaging; PET, positron emission tomography. To
            see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
FIG. 5. Redox reactions associated with EPR-visible species (spectra on the right). Top row. Nitroxides are stable in
solutions, but not in biological systems, and can be sensors of redox status due to illustrated reactions. The basic structure
can be the pyrrolidine or piperidine ring, which determines relative resistance to reduction (5-membered rings are generally
more resistant). These two pairs: hydroxylamine/nitroxide and nitroxide/oxoamonium cation actually mimic cycling anti-
oxidant and superoxide dismutase pairs. The group on the position 3 determines the behavior of the probe (solubility,
lipophilicity, membrane penetration, in vivo clearance rate, etc.) and can be tailored to the needs. Middle row. Spin trapping.
ROS are trapped with the nitrone trap converting them into a more stable form. Spectrum shows the ability of a trap
DEPMPO (5-dietoxyphosphoryl-5-methyl-1-N-oxyde) to capture both superoxide and hydroxyl radicals that can be dis-
tinguished by characteristic spectral lines. Bottom row. Trapping of NO using DETC (diethyldithiocarbamate) or MGD (N-
Methyl-D-glucamine dithiocarbamate) with different lipid solublility and membrane permeability. Adapted from Berliner
and Fujii (7). Reprinted with permission of AAAS. EPR, electron paramagnetic resonance.
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can at best accommodate a mouse tail due to nonresonant ab-
sorption of the electromagnetic radiation by the dielectric liq-
uids in biological systems. Imaging of small animals, thus, has
been performed at L-band (1.2 GHz) or even lower frequencies
(around 700 or 300 MHz) (10). Commercial EPRI machines
suitable for in vivo applications were not available until re-
cently; hence, most researchers used and still are using home-
made apparatus or a modification of commercial ones.
The realization that one can introduce metabolically re-
sponsive and relatively stable paramagnetic free radicals in the
body and detect these processes promptly stimulated the in-
troduction of MR in the area. MRI detects paramagnetic spe-
cies indirectly, since they increase the relaxation rate of water
molecules that can be seen by the enhanced signal on T1-
weighted images. At the beginning, nitroxides were studied as
potential clinical contrast agents, primarily for tumors, but
recently they are more often used to study the redox state (14).
MRI has no problems in imaging subjects of any size, including
humans, since it operates in the frequencies of a few hundreds
of MHz, but detection of ROS is indirect.
Both techniques have their advantages and drawbacks in
in vivo ROS detection/imaging but the sensible simultaneous
use of both is a way to employ the potential of these tech-
niques, which has been demonstrated even for solutions (8).
Namely, EPRI does not provide images of anatomy, it just
shows the distribution of injected nitroxide within the body,
and it does not have good spatial resolution. Conversely, MRI
has excellent spatial resolution, but it gives little or no in-
formation on the paramagnetic species involved. Hence, us-
ing MR as an imaging modality and EPRS in combination
can provide unique information (35, 37). It is also possible to
use both techniques as imaging modalities and overlay EPRI,
providing redox information apart from MRI providing an-
atomic information (15, 44, 57).
Numerous examples of combining these two techniques in
oxymetry imaging can be found elsewhere (2, 81, 82). There
are also constructions of dual EPR/MR imaging machines
(32, 39, 116). Probably the best way to fuse EPR and MRI
into a single machine is to use the dynamic nuclear polari-
zation (DNP or Overhauser effect) that uses a unique method
              for radical detection (see below). An entirely different ap-
proach has been the combination of X-ray CT with EPRI in
studying a mouse knee (11).
Perhaps the most powerful application of in vivo EPRI is
measurement of oxygen (EPR oxymetry). This subject will not
be covered per se due to limited space, although it is closely
connected with the scope of this article. In addition, this sub-
ject has been extensively and regularly reviewed. What fol-
lows are characteristic examples that illustrate applications of
magnetic resonance techniques in imaging ROS, particularly
emphasizing how fruitful a combination of EPR and MRI can
be in achieving optimal analysis of the investigated subject. A
more comprehensive list of examples and a literature overview
on EPR imaging of the oxidative stress can be found in the
recent review (28), and more technical aspects of various EPR
and MRI approaches with examples can be found in (56, 90).
Examples of EPRI/MRI of ROS/RNS
Early EPRI images were rather crude (same as first MRI),
and it took some 5–6 min to make crude 2D images using
filtered back-projection with only eight projections resulting
in low spatial resolution. (3, 111). It took full 45 min to obtain
a complete 3D data set (60), which certainly limits temporal
studies. However, this research stimulated further develop-
ment, and today’s machines are capable of producing 3D
EPR images in around 1 min with up to 80 projections, where
the actual performance depends on a selected task (34, 55,
155). Most research using EPRI and MRI was conducted
using derivatives of TEMPO and PROXYL. In the beginning,
carboxyl-PROXYL (3CxP, or then termed PCA) has been
used (3, 4, 111), but later carbamoyl-PROXYL (3CP) became
almost the universal choice for imaging, although different
derivatives, such as hydroxylmethyl (HM-P) and others, have
been used, especially in brain imaging (118, 151, 155). The
proper selection of these probes with different properties such
as in vivo half-life, membrane permeability, lipid solubility,
etc. enables clarification of the location of in vivo ROS
generation and redox status. As a rule, piperidine nitroxides
have an in vivo half-life of a few minutes whereas the half-life
of pyrrolidine is typically around 15 min or more. This is why
pyrrolidines are generally used to image metabolism whereas
piperidines are useful for probe circulation.
Brain imaging (without tumors)
The brain, due to its complex structure and function, has
been a natural target for ROS EPR/MR imaging since the
beginning of development of EPRI (60). This research has
been accelerated by synthesis of the blood-brain-barrier
permeable nitroxides (117, 140) and instrumental develop-
ments. Yokoyama et al. published a nice series of articles on
various conditions induced in experimental animals (149,
150, 152–154). Figure 6 illustrates the basic concept of time-
resolved brain EPRI (153). In rats with kainic-acid (KA)-
induced seizures, the hippocampal half-life of nitroxide
(PCAM) after KA-induced seizures was significantly pro-
longed, indicating impaired reducing ability; whereas the
prolongation of the cortical half-life was not significant.
These findings were confirmed by using an acyl-protected
hydroxylamine that undergoes intracellular oxidation to
nitroxides (150), showing that oxidative stress in the hippo-
campus and striatum in KA-treated animals is enhanced, but
not in the cortex. Another set of studies, performed on the
effect of various neuroleptics that are known to induce oxi-
dative stress on the brain, revealed diminished ability of
various brain areas in treated animals to reduce injected
nitroxide (149, 152, 154). The study on intracerebral-
reducing ability after acute stress in adult rats showed di-
minished reducing ability in rats that were subjected to
neonatal isolation (154). Studies employing ischemia-
reperfusion (I/R) injury induced by mid-carotid-artery oc-
clusion using either only MRI (13) or EPRI/MRI combina-
tion (52) revealed slower reduction rates in brains that have
undergone I/R. Another common way of altering the redox
state is to induce septic shock, and it was shown that reduc-
tion rates of injected nitroxides are accelerated in brains of
septic mice (36). Radiation is a certain way to induce vast
changes in redox status, and various nitroxides have been
successfully tested as potential radioprotectors (see (23) and
references cited therein). In that study, nitroxides were used
as both radioprotectors and indicators of redox status, and
pharmacokinetics of nitroxides in brain, salivary gland, ton-
gue, and oral muscle have been determined using MRI.
ROS IMAGING 9
ARS-2015-6415-ver9-Maulucci_1P.3d 05/26/16 5:12pm Page 9
Tumor imaging
Due to their heterogeneous structure, tumors have been
studied since the introduction of EPRI (9, 26). Redox status
and oxygenation are important in designing therapy (espe-
cially radiotherapy) and/or in assessing tumor response to 
therapy. Tumors are heterogeneous in both aspects; hence, it is 
desirable to obtain spatially resolved images of nitroxide dis-
tribution and clearance simultaneously within the tumor vol-
ume as well as oxygenation, if possible. Various approaches 
employing the EPR/MRI combination, or individual technique
and probe selection, have been used (37, 40, 54, 58, 73, 74, 98,
113, 132, 146, 156). An example of tumor heterogeneity in
 reduction rates of nitroxide is given in Figure 7. It has been 
generally concluded that the reduction of nitroxides in tumors
is faster than in normal tissue, irrespective of whether the re-
duction in tumors implanted in the muscle is compared with
the muscle (54, 58, 73, 74, 146) or when gastric cancer is
compared with normal mucosa (98). Faster bioreduction in
tumors can be a consequence of an increased amount of en-
dogenous reducing agents such as thiols [reduction was slower
in both normal tissue and tumor in animals depleted with thiols
(74, 146)], ascorbate, enzymes (Fig. 7). Chemically, nitroxides
do not react with thiols, but altering the concentration of the
thiol or changing the ratio of redox pairs has an impact on the
clearance of the nitroxide; therefore, in vivo reduction of
nitroxides also depends on the oxygen content and on the
levels of GSH (74). Lack of oxygen, reflecting the well-known
fact that reduction is faster in oxygen-depleted tissues, may
also be responsible and tumors tend to have large hypoxic
regions. Studies of tumors in animals breathing carbogen
showed decreased reduction of nitroxides and decreased re-
duction heterogeneity with increased oxygenation (58), but a
simultaneous study on reduction of nitroxides and direct
oxymetry showed a rather poor correlation between these in
normal air-breathing animals (132).
FIG. 7. EPRI of the thigh of mouse with implanted RIF-1 tumor. Left: Selected EPR images of clearance of 3CP
nitroxide in untreated and BSO-induced (agent for glutathione synthesis) tumors. Middle: Redox mapping of the tumor.
Two dimensional mapping of pseudo-first-order rate constants and frequency plot of 3CP reduction rate constants. Right.
The semilog plot showing the whole tissue clearance of nitroxide in tumors and normal muscle of contra lateral leg. Images
of tumor and muscle used for the measurement of pharmacokinetic data were collected simultaneously on the same animals.
Adapted from Kuppusamy et al.(74). Reprinted with permission of AACR. To see this illustration in color, the reader is
referred to the web version of this article at www.liebertpub.com/ars
FIG. 6. EPRI of rat brain. Left. The dynamic pattern of selected transversal EPR images of rat head 5 mm posterior to
the bregma in the KA-treated and control groups at different times after injection of PCAM nitroxide. Right. Pharmaco-
kinetic curves for brain regions. The cortical half-lives of PCAM in the control and KA groups were 18.0 – 1.2 and
19.2 – 0.7 min, whereas the hippocampal half-lives of PCAM in the control and KA groups were 10.4 – 0.8 and
15.9 – 0.7 min, respectively. Adapted from Yokoyama et al. (153). Reprinted with permission of ELSEVIER. KA, kainic-
acid. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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Other organs
Skin is an ideal target organ for EPRI for several reasons.
Imaging of ROS does not require a large penetration depth, so
one can use the S-band (2.2–3.0 MHz) for in vivo specimens
or even X-band for in vitro specimens, which results in im-
proved sensitivity. Imaging does not require full 2D or 3D;
once nitroxides are applied topically, a simple spectral-
spatial 1D imaging with one gradient orthogonal to the skin
surface is sufficient to obtain distribution of nitroxides and
redox status in different skin layers. Surface loop coils are
sufficient, that is, the whole object need not to be within the
resonator, which allows EPRI of objects of any size, in-
cluding humans. The potential of this technique has been
nicely demonstrated in an in vivo study of human skin (46),
which opens the possibilities of studying various skin pa-
thologies, aging, or photo-damage. The effect of UV expo-
sure on free radical production and redox status of the skin
has been studied both in vivo and in vitro (45–47).
Pharmacokinetics of nitroxides in abdominal organs (liver,
kidneys, bladder) was first studied by in vivo EPRS (4) and
EPRI (3, 111). The distribution and reduction/clearance of
nitroxides demonstrated the feasibility of EPRI studies. But
apart from having low spatiotemporal resolution, it has re-
vealed difficulties in anatomical localization of different organs
on EPR images. A decade later, it has been shown that this
problem can be overcome by combining EPRI and MRI (44,
57) and that whole-body simultaneous measurements of phar-
macokinetics and distribution of nitroxides can be performed
on ten different locations within the body (57). These studies
were performed to illustrate technical developments, and they
were not aimed at investigating any particular pathology. An 
excellent application of a hybrid EPR/MRI machine has stud-
ied the redox status of different organs in mice exposed to 
cigarette smoke (Fig. 8). On the other hand, different important 
pathologies were studied using less technically demanding
direct time-resolved EPRI. The study of mice liver showed a
much slower reduction of 3CP in carbon-tetrachloride dam-
aged liver than in the control (135). Another study of mice with
hepatic I/R injury showed that CV159-Ca2+/calmodulin
blockade inhibiting Ca2+ overloading has a profound effect on
the liver-reducing ability (69). The I/R acute renal failure
produced prolonged reduction of 3CP in kidneys (48), whereas
it was much faster in the kidneys of diabetic mice (128). The
latter study also showed that treatment with angiotensin returns
the reduction to the control level, confirming the antioxidant
properties of this drug. Another drug (Azelnidipine) has been
studied in the murine hypertension model, and it has been
found that it improves renal-reducing ability of free radicals,
thus ameliorating the renal redox status (49). A somewhat
different model of the investigated pathology was employed in
a study of reducing activity of kidneys in Nrf2 transcriptional
factor-deficient mice. The combination of deficiency and aging
resulted in four times longer half-life of 3CP in the upper ab-
domen than in juvenile wild-type mice, indicating that low
reducing ability may play a role in the onset of autoimmune
nephritis (50). A set of hydroxylamine spin probes detecting
site-specific production of the superoxide radical and allowing
subcellular resolution and organelle specificity was developed
and used in vivo on several organs. The detection mechanism is
based on a rapid reaction of cyclic hydroxylamines with su-
peroxide, producing stable nitroxides (25). These probes were
applied in vivo on old rats, showed how ROS generation was
significantly increased compared with their young counterparts
in blood, skeletal muscle, lung, and heart, but did not change in
intestine, brain, liver, and kidney (71).
Imaging of trapped radicals
This attractive modality offers a possibility to image spe-
cific ROS as opposed to previous examples where the overall
redox state was imaged. However, EPRI of trapped ROS is
FIG. 8. Renderings of the superimposed 3D EPRI and 3D proton MRI of mice. The color map is for the EPR intensity
of the 3CP nitroxide probe distribution. Left. Coronal MR image of mice. Right. Transverse slices through different organs
of the animal showing the temporal change of EPR intensity of 3CP. The green contour depicts the ROI used to calculate the
average EPR intensity distribution of the probe later used to assess pharmacokinetics. Based on that, it has been found that
mice exposed to second-hand smoking have diminished ability to reduce nitroxides in these organs. Adapted from Caia
et al. (15). Reprinted with permission of ELSEVIER. To see this illustration in color, the reader is referred to the web
version of this article at www.liebertpub.com/ars
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extremely difficult. First, the concentration of radicals is very
low and it requires very high amounts of spin trapping agent
to be injected (up to 100 mmol/kg), which raises the question
of toxicity. Second, EPR spectra of trapped radicals usually 
contain numerous closely spaced lines of multiple adducts
(Fig. 5) and it is almost impossible to isolate specific lines for 
imaging the selected adduct. Third, trapped products are not
very stable, which narrows the time window for imaging.
 Nevertheless, imaging of trapped NO (Fig. 9) is a good ex-
ample of how to combine in vivo EPR and MRI. The role of
in vivo EPR is not to image radicals but to add the unique 
information on the nature of the radical species (finger-
printing), which actually enhances the tissue signal on T1W 
MRI, and a similar approach has been employed in brain 
imaging (36). Although there are no true images of trapped 
radicals, useful in vivo studies have been performed for em-
ploying specific EPR coils that detect signals only from tar-
geted organs in assessing the usefulness of different traps in 
detecting radicals (134), NO generation in mice after car-
diopulmonary arrest (75), and studies of simultaneous de-
tection of oxygen and NO in the induced septic shock (33). 
Another example of successful in vivo detection of trapped
radical is on the irradiated mouse, since irradiation produces a
large amount of free radicals (43). Imaging of spin-trapped
superoxide or hydroxyl radical could be improved by de-
veloping more resistant spin traps and using 15N-substituted
probes, which will improve sensitivity and resolution by
decreasing the number of EPR lines [see the nice review on
in vivo trapping (64)].
Dynamic nuclear polarization DNP-MRI
(OMRI, PEDRI)
This technique deserves to be treated separately due to the
unique detection mechanism and high potential for in vivo
measurements, although the aim of these studies is the same
as outlined earlier. DNP is not a simple overlaying of separate
EPR and MR images obtained in a hybrid apparatus but a
technique that includes parts of EPRI and MRI. Detection of
radicals (unpaired electron spin) is based on a different
principle. There are several DNP mechanisms (89), but most
of the biological applications have been performed using the
classical Overhauser effect, hence Overhauser MRI or
OMRI. The first experiment using nitroxides and transfer to
FIG. 9. LPS treated rats. Left: T1W MRI images of the rat abdomen both before and after injection of the NO spin
trap. Right: EPR spectra of trapped NO in-vivo on L-band (a) and on excised sample X-band (b), demonstrating that trapped
radical is NO and that MRI signal enhancement originates from NO. Adapted from Gallez et al. (37). Reprinted with
permission of Wiley.
FIG. 10. Left. Interleaved (‘‘EPR off’’ and ‘‘EPR on’’) OMRI images (coronal) of bearing SCC tumor on the right
hind leg, demonstrating the OE and the diagnostic quality achievable at this low magnetic field of 15 mT. The mouse
was administered 3.8 mmol/kg triarymethyl radical by tail vein (72). Right. OMRI images of rat brain microinjected with
neurodegenerative changes inducing agent (6-OHDA) into right hemisphere striatum. Redox status assessed 6 weeks later
by the time-dependent OMRI signal of i.v.-injected methoxycarbonyl-PROXYL and the processed image showing the
reduction rates in two hemispheres, demonstrating diminished reducing compatibilities in affected hemisphere. Adapted
from Yamato et al. (147). Reprinted with permission of ELSEVIER. OE, overhauser enhancement. To see this illustration in
color, the reader is referred to the web version of this article at www.liebertpub.com/ars
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protons was performed almost 30 years ago (86) and was
referred to as PEDRI (proton electron double resonance im-
aging). Briefly, the two-spin system (e.g., nitroxide/water
protons) in the magnetic field is irradiated by RF at an EPR
frequency of nitroxides (unpaired electron); magnetization is
transferred to protons enhancing water proton NMR signal
intensities; and the overall effect is detected by conventional
proton MRI (86). This effect is completely different from
classical enhancement of proton relaxation by nitroxides
(theoretically 330 times higher). This is illustrated in Figure 10
on MRI of nitroxide-infused mice (72). Without EPR, RF ir-
radiation nitroxides are invisible since classical enhancement is
weak, whereas they can be clearly seen in the ‘‘EPR on’’ mode.
Some nice examples (Fig. 10B) on the usefulness of this
technique in imaging of the brain redox status have been
published (147, 148). The OMRI combines the sensitivity of
EPR with the advantages of MRI, thus presenting an ideal
machine for ROS imaging. However, OMRI apparatus has to
be home-built, which requires substantial skill and resources.
The impetus for further development may come from the fact
that in vivo DNP-MRI has an intrinsic capacity for molecular
imaging of multiple species, similar to MR chemical shift
imaging. By changing the frequency of EPR irradiation in
DNP-MRI, distinct images of different radicals having differ-
ent EPR spectra can be obtained, which has been demonstrated
in an experiment where nitroxides labeled with 14N or 15N were
simultaneously imaged (141). This approach was further ex-
tended, although in test tubes, to simultaneous imaging of free
radical intermediates involved in the mitochondrial electron
transport chain and radicals derived from vitamins E and K1
(53). Being able to simultaneously image species with a het-
erogeneous broad line having poor hyperfine splitting or spe-
cies with complicated hyperfine splitting lines, which is
impossible for standard EPRI, opens a host of possibilities,
including metabolic imaging in various pathologies and im-
aging of spin-trapped radicals.
Conclusions
The relevance of ROS in human physiopathology is now a
well-established clinical notion (30). Reactive species are
essential regulators in the physiopathology of disease; the
knowledge of their concentration and local distribution with
subcellular resolution is, therefore, a necessary clinical tool.
This can be achieved by using different approaches based on
the detection of redox couples, biomarkers that specifically
bind to a redox species or that can modify their properties in
the presence of ROS or some by-product of the oxidation
(Fig. 1). The most investigated solution is the ‘‘photonic’’
one. A wide variety of fluorescent probes and fluorescent NPs
in the visible range, specific for each redox couples, allow
redox mapping with 200 nm resolution, according to the
Abbe law. Recently, new optical techniques (Stimulated
emission-depletion fluorescence microscopy, photoactivated
localization microscopy, etc.) (80, 144) have been developed
to break down the resolution limit up to 20 nm, but specific
probes are needed and, at the moment, these are unavailable
for redox detection. Instead, the development of redox-
sensitive fluorescent probes allowed a quantitative detection
of each component of each of the redox couples, representing
a further step ahead toward the comprehension of ROS in-
volvement in the human physiopathology.
For these reasons, fluorescence microscopy not only has
become very popular in biomedical research activities (i.e.,
on cell lines) but also has found relevant translation appli-
cations in the histopathology of tissues from biopsies and in
the investigation of dermal injuries (i.e., melanoma detec-
tion) (109).
These techniques, however, suffer from two main draw-
backs that hampered their potential translational applications:
(i) the low penetration of the visible light into tissues (roughly
300 nm) due to the tissues’ optical absorbance (mainly due to
hemoglobin) and multiple scattering, and (ii) the toxicity of
fluorescent probes. TPM with endogenous or chemo-selective
probes offers an attractive approach to in vivo ROS detection,
due to the probes’ general compatibility with many biological
systems without external activating enzymes and genetic
manipulation. TPM for in vivo and internal tissue imaging by
using endogenous probes is a very attractive option and has
stimulated the development of TPM microendoscopes by us-
ing a gradient-index rod lens, miniature compound lens (68,
114). Otherwise, to avoid the low signal-to-noise ratio pro-
vided by endogenous or chemo-selective probes, and to in-
crease the penetration depth, the use of TP-excited IR and
chemiluminescent probes has been proposed.
Microscopy in the NIR-VIS region of the electromagnetic
spectrum is therefore very promising, although it may suffer
due to limited clinical applications, when large spatial areas
have to be scanned. Indeed, if we are interested in ROS
distribution on a large scale (i.e., on the whole organ of a
human being), we need different approaches. These can be
furnished by intriguing applications of techniques commonly
adopted in clinical investigation.
Ultrasound-based techniques, as demonstrated for the APL
bio-sensors, allow a detection of physiological concentrations
of ROS, with a contrast and a spatial resolution that can exceed
those provided by fluorescence and chemiluminescence-based
contrast agents. Evaluation is possible on a rapid time-scale
(minutes), and imaging systems are in widespread clinical use.
However, although toxicity of APLs and MMCs remains a
concern, functionalizing these agents allows a selective de-
struction of target tissues.
Toxicity is a minor feature for PET and SPECT that are
noninvasive, but they do involve exposure to ionizing radi-
ation. Besides its established role as a diagnostic technique,
PET has an expanding role as a method to assess the response
to therapy, in particular, cancer therapy, where the risk to the
patient from lack of knowledge about disease progress is
much greater than the risk from the test radiation. The prin-
cipal concern in PET and SPECT redox imaging is the lack of
radiolabeled molecules that bind to ROS, and that has limited
success of nuclear medicine in the direct imaging of ROS.
Nevertheless, indirect methods for imaging of glucose con-
sumption, redox potential, hypoxia, as well as direct imaging
of ROS scavengers and mitochondrial complexes have un-
disputable clinical interest. Considering the sustained efforts
in development of new isotopes and labeling methods, PET
and SPECT are poised to make significant contributions to
the field in the future. Another limitation is the resolution of
clinical and preclinical PET cameras (roughly 1 mm).
The EPR and MR imaging in vivo has become a powerful
tool in experimental and preclinical studies of ROS/RNS or
redox status on animals. Basic concepts are well understood,
and directions for future developments are clear. On the
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instrumental side, further development of hybrid machines is
an obvious goal. The problem remains that these machines are
expensive and have to be more or less home-built. On the side
of probes and traps, the development of those that show
specificity toward certain ROS, specificity toward certain or-
gans (e.g., tumors) and showing longer in vivo life time is
required; some studies along these lines are already underway
(1, 85, 107, 113). The major obstacle in the translation of these
techniques to the clinic is the scarcity of centers possessing the
equipment, and the lack of a focused concerted effort on cer-
tain clusters of widely relevant pathologies in which ROS may
play a key role (e.g., Amyotrophic Lateral Sclerosis, Parkin-
son, Alzheimer, and other neurodegenarative diseases). Clin-
ical application of EPR spectroscopy has been summarized
recently (65), stating that the best perspectives are in oximetry
and dosimetry ionizing irradiation. One can add certain po-
tential in investigating skin pathologies, including melanoma,
to the list, but, due to problems with penetration depth of
microwaves, EPRI of human body analogous to MRI will
never be possible. On the other hand, it has been successfully
demonstrated that OMRI machines accommodating large
subjects, including humans, can be built (72, 87), opening
possibilities to combine all MRI capabilities with molecular
specificity of EPR in diagnosis and treatment follow-up.
Outlook
Potential clinical translation of ROS imaging is straight-
forward. Each of the presented techniques possess an at-
tractive potential, but none of them can fulfill all the
requirements in terms of sensitivity, spatial resolution, tem-
poral resolution, probe availability, toxicity, and cost. The
obvious solution is to perform parallel studies with two or
more techniques or even better to integrate imaging modal-
ities that may offer synergistic advantages over any single
modality alone. Some hybrid imaging systems such as PET/
CT, SPECT/CT, PET/MRI, and EPR/MRI have already been
developed. Anatomical imaging techniques such as CT and
MRI provide structural details; whereas functional modalities
such as PET, SPECT, TP-fluorescence, EPR, and others
provide insight into functional and metabolic aspects. In-
corporation of anatomical and functional imaging in a com-
mon hybrid imaging platform should allow improved
diagnosis, therapeutic planning, and follow-up studies.
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Abbreviations Used
APL¼ allylhydrazine encapsulated in phospholipid
liposomes
EG¼ glutathione intracellular redox potential
EPR¼ electron paramagnetic resonance
FAD¼flavin adenine dinucleotide
FDG¼ [18F]Fluorodeoxyglucose
FMN¼flavin mononucleotide
Grx1¼ glutaredoxin 1
GSH¼ glutathione
GSSG¼ glutathionedisulfide
H2O2 ¼ hydrogen peroxide
HO2$¼ hydroperoxyl radical
HOCl¼ hypoclorous acid
HyPer¼H2O2 fluorescent sensor
I/R¼ ischemia-reperfusion
KA¼ kainic-acid
MMC¼micromotor converters
MPO¼myeloperoxidase
MRI¼magnetic resonance imaging
NAD¼ nicotinamide adenine dinucleotide
NADP¼ nicotinamide adenine dinucleotide phosphate
NADPH¼ nicotinamide adenine dinucleotide phosphate
NIR¼ near-infrared
NO¼ nitric oxide
NOS¼ nitric oxide synthase
NOX¼NADPH oxidase
NP¼ nanoparticles
O2
-¼ superoxide radical
ONOO-¼ peroxynitrite radical
PEDRI¼ proton electron double resonance imaging
PET¼ positron emission tomography
PN1¼ peroxy naphthalene 1
PROXYL¼ 2,2,5,5-tetramethylpyrrolidine 1-oxyl
RNS¼ reactive nitrogen species
roGFP¼GSH-sensitive green fluorescent protein
ROS¼ reactive oxygen species
rxYFP¼GSH-sensitive yellow fluorescent protein
SHG¼ second harmonic generation
SPECT¼ single-photon emission computed
tomography
TEMPO¼ 2,2,6,6-tetramethylpiperidine 1-oxyl
TP-FLIM¼ two-photon fluorescence lifetime
imaging microscopy
TP-FRIM¼ two-photon fluorescence ratio
imaging microscopy
TPM¼ two-photon microscopy
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